SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Bahadoer Renu R.)
 

Sökning: WFRF:(Bahadoer Renu R.) > Quality of life and...

  • Dijkstra, Esmee A.Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands. (författare)

Quality of life and late toxicity after short-course radiotherapy followed by chemotherapy or chemoradiotherapy for locally advanced rectal cancer - The RAPIDO trial

  • Artikel/kapitelEngelska2022

Förlag, utgivningsår, omfång ...

  • Elsevier,2022
  • electronicrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:uu-477779
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-477779URI
  • https://doi.org/10.1016/j.radonc.2022.04.013DOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:149723977URI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • Background and purpose: The RAPIDO trial demonstrated a decrease in disease-related treatment failure (DrTF) and an increase in pathological complete responses (pCR) in locally advanced rectal cancer (LARC) patients receiving total neoadjuvant treatment (TNT) compared to conventional chemoradiotherapy. This study examines health-related quality of life (HRQL), bowel function, and late toxicity in patients in the trial.Materials and methods: Patients were randomized between short-course radiotherapy followed by pre-operative chemotherapy (EXP), or chemoradiotherapy and optional post-operative chemotherapy (STD). The STD group was divided into patients who did (STD+) and did not (STD-) receive post-operative chemotherapy. Three years after surgery patients received HRQL (EORTC QLQ-C30, QLQ-CR29 and QLQ-CIPN20) and LARS questionnaires. Patients who experienced a DrTF event before the toxicity assessments (6, 12, 24, or 36 months) were excluded from analyses.Results: Of 574 eligible patients, 495 questionnaires were returned (86%) and 453 analyzed (79% com-pleted within time limits). No significant differences were observed between the groups regarding QLQ-C30, QLQ-CR29 or LARS scores. Sensory-related symptoms occurred significantly more often in the EXP group compared to all STD patients, but not compared to STD+ patients. Any toxicity of any grade and grade > 3 toxicity was comparable between the EXP and STD groups at all time-points. Neurotoxicity grade 1-2 occurred significantly more often in the EXP and STD+ group at all time-points compared to the STD-group.Conclusion: The results demonstrate that TNT for LARC, yielding improved DrTF and pCRs, does not com-promise HRQL, bowel functional or results in more grade >3 toxicity compared to standard chemoradio-therapy at three years after surgery in DrTF-free patients.(c) 2022 The Authors. Published by Elsevier B.V. Radiotherapy and Oncology 171 (2022) 69-76 This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Hospers, Geke A. P.Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands. (författare)
  • Kranenbarg, Elma Meershoek-KleinLeiden Univ, Dept Surg, Med Ctr, Leiden, Netherlands. (författare)
  • Fleer, JokeUniv Groningen, Univ Med Ctr Groningen, Dept Hlth Sci, Sect Hlth Psychol, Groningen, Netherlands. (författare)
  • Roodvoets, Annet G. H.Leiden Univ, Dept Surg, Med Ctr, Leiden, Netherlands. (författare)
  • Bahadoer, Renu R.Leiden Univ, Dept Surg, Med Ctr, Leiden, Netherlands. (författare)
  • Guren, Marianne G.Oslo Univ Hosp, Dept Oncol, Oslo, Norway. (författare)
  • Tjalma, Jolien J. J.Univ Groningen, Univ Med Ctr Groningen, Dept Gen Practice, Groningen, Netherlands. (författare)
  • Putter, HeinLeiden Univ, Dept Med Stat & Bioinformat, Med Ctr, Leiden, Netherlands.,Amphia Hosp, Dept Surg, Breda, Netherlands. (författare)
  • Crolla, Rogier M. P. H.Amphia Hosp, Dept Surg, Breda, Netherlands.,Northwest Clin, Dept Med Oncol, Alkmaar, Netherlands. (författare)
  • Hendriks, Mathijs P.Northwest Clin, Dept Med Oncol, Alkmaar, Netherlands. (författare)
  • Capdevila, JaumeAutonomous Univ Barcelona UAB, Vall Hebron Univ Hosp, Vall Hebron Inst Oncol VHIO, Dept Med Oncol, Barcelona, Spain. (författare)
  • Radu, Calin,1969-Uppsala universitet,Experimentell och klinisk onkologi(Swepub:uu)calra471 (författare)
  • van de Velde, Cornelis J. H.Leiden Univ, Dept Surg, Med Ctr, Leiden, Netherlands. (författare)
  • Nilsson, Per J.Karolinska Institutet,Karolinska Univ Hosp, Dept Surg, Stockholm, Sweden. (författare)
  • Glimelius, BengtUppsala universitet,Experimentell och klinisk onkologi(Swepub:uu)bengglim (författare)
  • van Etten, BoudewijnUniv Groningen, Univ Med Ctr Groningen, Dept Surg, Groningen, Netherlands. (författare)
  • Marijnen, Corrie A. M.Netherlands Canc Inst, Dept Radiat Oncol, Amsterdam, Netherlands.;Leiden Univ, Dept Radiat Oncol, Med Ctr, Leiden, Netherlands. (författare)
  • Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands.Leiden Univ, Dept Surg, Med Ctr, Leiden, Netherlands. (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Radiotherapy and Oncology: Elsevier171, s. 69-760167-81401879-0887

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy